Coverage
-
June 05, 2018
An Illinois federal judge on Tuesday awarded Pomerantz LLP and Glancy Prongay & Murray LLP more than $6 million in attorneys' fees in a class action brought by Akorn Pharmaceuticals investors who claimed that Akorn Inc. failed to properly track its finances, leading the company to misstate its revenue.
4 other articles on this case.
View all »